Award
NIH Reporter #5SB1AI186689-02
A Point of Care Urine Test to Aid Diagnosis of Aspergillosis
Recipient
PEARL DIAGNOSTICS, INC.
Award Amount
$977,071.00
Ceiling
$977,071.00
Awarded
June 30, 2026
Identifier
5SB1AI186689-02
Award to Pearl Diagnostics, Inc. for developing a urine-based diagnostic test for invasive aspergillosis to improve early detection and treatment. The project is funded by NIAID with a total amount of $977,071 and spans from July 24, 2025 to June 30, 2028.
Description
Development of a rapid, easy to use urine test to detect invasive aspergillosis, a lung infection caused by fungal spores, to enable earlier diagnosis and therapy. The project involves optimization, clinical testing, and regulatory approval of a lateral flow device for point of care testing.